Tvardi Therapeutics Q3 EPS $(0.59) Beats $(0.92) Estimate
Benzinga Newsdesk 12 months ago
EarningsEarnings BeatsNews
Tvardi Therapeutics (NASDAQ:TVRD) reported quarterly losses of $(0.59) per share which beat the analyst consensus estimate of $(0.92) by 35.8 percent.
Tvardi Therapeutics (NASDAQ:TVRD) reported quarterly losses of $(0.59) per share which beat the analyst consensus estimate of $(0.92) by 35.8 percent.